News
Aug 10
Ketamine May Relieve Depression Quickly For Those With Treatment-Resistant Bipolar Disorder
A single intravenous dose of the anesthetic agent ketamine appears to reduce symptoms of depression within 40 minutes among those with bipolar disorder who have not responded to other treatments, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives jo…… read more »
Aug 8
Study Shows Possibilities for Predicting How Patients Will Respond to Antidepressants
In a study of an experimental treatment for major depression, pretreatment testing to probe the function of a specific brain center predicted how patients would respond to ketamine, a medication that can lift depression rapidly in some people. The work suggests it may be possible to develop ways to use…… read more »
Aug 8
Recovery After an Initial Schizophrenia Episode (RAISE): A Research Project of the NIMH
Recovery After an Initial Schizophrenia Episode (RAISE) is an NIMH research project that seeks to fundamentally change the trajectory and prognosis of schizophrenia through coordinated and aggressive treatment in the earliest stages of illness. RAISE is designed to reduce the likelihood of long-term…… read more »
Jul 18
NAMI Consumer Council Honors Paolo Del Vecchio Associate Director, SAMHSA's Center For Mental Health Services
The Consumer Council of the National Alliance on Mental Illness (NAMI) has honored Paolo del Vecchio with its annual Gloria Huntley Award that recognizes an individual or organization that has made significant strides in reducing the use of restraints and seclusion in the treatment of mental illness…… read more »
